Skip to main content
. 2022 Feb 4;11:574318. doi: 10.3389/fonc.2021.574318

Figure 3.

Figure 3

Statistical comparison among the four clinical groups. (A) PCA, (B, D) PLS-DA, and (C, E) random forest tests were performed to identify group characteristics and potential metabolite biomarkers along with CRC treatment. Group A, CRC patients before surgery; Group B, CRC patients after surgery; Group C, CRC patients after chemotherapy; and Group N, healthy control group.